Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Sharlene Su

Physical Medicine & Rehabilitation Reno, NV Medical Doctor

NPI 1548622640 CMS profile 8730194

10085 Double R Blvd Ste 205, Reno, NV 89521

Open in the dashboard

General payments

$14,679

122 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Sharlene Su of Reno, NV is reported in the CMS Open Payments database as having received $14,679 across 122 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Physical Medicine & Rehabilitation profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,094 11
2024 General $1,079 11
2023 General $1,746 12
2022 General $6,177 37
2021 General $4,475 49
2020 General $108 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sharlene Su
  • Physical Medicine & Rehabilitation median
  • Middle half of Physical Medicine & Rehabilitation
  • National median

In program year 2025, general payments to Sharlene Su were reported at $1,094. Among 4,146 Physical Medicine & Rehabilitation profiles paid that year, the median was $139 and the middle half received between $48 and $410.

Show as a table
Year Sharlene Su Physical Medicine & Rehabilitation median Middle half National median
2019 $0 $133 $45–$390 $163
2020 $108 $88 $29–$272 $114
2021 $4,475 $116 $33–$360 $132
2022 $6,177 $123 $40–$378 $149
2023 $1,746 $131 $43–$396 $160
2024 $1,079 $141 $45–$409 $164
2025 $1,094 $139 $48–$410 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Medtronic, Inc. $8,430 61 payments
  2. Boston Scientific Corporation $1,715 17 payments
  3. SPR Therapeutics, Inc $1,243 12 payments
  4. Abbott Laboratories $946 13 payments
  5. Avanos Medical $705 1 payment
  6. Nevro Corp. $561 6 payments
  7. Nalu Medical, Inc. $493 5 payments
  8. Painteq LLC $305 2 payments
  9. Medtronic USA, Inc. $108 2 payments
  10. Saluda Medical Americas, Inc. $103 1 payment
  11. Other $69 2 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Travel and Lodging $6,421 38 payments
  2. Food and Beverage $5,947 80 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,300 1 payment
  4. Consulting Fee $705 1 payment
  5. Education $305 2 payments
Products named General payments · program years 2020–2025
  1. INTELLIS ADAPTIVESTIM $3,738 18 payments
  2. KYPHON Balloon Kyphoplasty $2,490 23 payments
  3. KYPHON EXPRESS II KYPHOPAK TRAY $1,228 6 payments
  4. SPRINT PNS System $1,211 11 payments
  5. Superion Indirect Decompression System $963 8 payments
  6. GENERATOR $705 1 payment
  7. Proclaim IPG $533 6 payments
  8. Omnia $518 5 payments
  9. Nalu Neurostimulation System $493 5 payments
  10. PAINTEQ $305 2 payments
  11. Other $2,773 45 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 14 drugs

Part D claims

435

Median for Physical Medicine and Rehabilitation: 276

Drug cost

$8,322

Median for Physical Medicine and Rehabilitation: $5,921

Branded share of claims

23.2%

Median for Physical Medicine and Rehabilitation: 11.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Buprenorphine Generic 13 $3,544
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 42 $1,089
Gabapentin Generic 78 $1,067
Pregabalin Generic 25 $424
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 48 $421
Baclofen Generic 12 $352
Tramadol Hcl Generic 27 $258
Oxycodone Hcl Generic 29 $252
Tizanidine Hcl Generic 30 $223
Nortriptyline Hcl Generic 24 $190

The 10 drugs with the highest cost, of 14 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 7,591 Part D prescribers listed as Physical Medicine and Rehabilitation; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 56 billing codes

Paid by Medicare

$71,425

Of which drugs: $4,198

Medicare patients

188

Average age 74

Services billed

1,918

107 women, 81 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 73%
Depression 29%
Ischemic heart disease 27%
Diabetes 25%
COPD 20%
Osteoporosis 20%
Atrial fibrillation 19%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 31 234 $20

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

122 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physical Medicine & Rehabilitation in Nevada

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record